--2025/Q1-- / 3.000M--
--2024/Q4-- / 2.500M--
--2024/Q32.441M / 2.625M--
Aug 13, 20242024/Q22.400M / 3.155M--
May 9, 20242024/Q12.631M / 3.280M--
MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
NBY NovaBay Pharmaceuticals
- 0.5299
- +0.0258+5.12%
Close Dec 20 16:00 ET
- 0.5100
- -0.0199-3.76%
Post 19:59 ET
2.59MMarket Cap-0.01P/E (TTM)
0.5299High0.5046Low597.91KVolume0.5166Open0.5041Pre Close360.74KTurnover12.25%Turnover Ratio0.00P/E (Static)4.89MShares9.079052wk High2.43P/B2.59MFloat Cap0.361152wk Low--Dividend TTM4.88MShs Float130156.1979Historical High--Div YieldTTM5.02%Amplitude0.3610Historical Low0.6030Avg Price1Lot Size
NovaBay Pharmaceuticals Key Stats
NovaBay Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
NovaBay Pharmaceuticals Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data